John Wilding

47PUBLICATIONS
135CO-AUTHORS
Gene and molecular therapyCancer geneticsEducational counsellingPredictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Jul 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management.

|Jun 24, 2026
The Global Obesity Epidemic: Epidemiology, Health Burden and Policy Priorities.

|May 27, 2026
Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes.

|Apr 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.

|Apr 23, 2026
Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.

|Apr 21, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.

Pageof 8

Frequent Collaborators

8 joint publications

Avivit Cahn

7 joint publications

Lawrence A Leiter

6 joint publications

Deepak L Bhatt

5 joint publications

Itamar Raz